Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 7096 to 7110 of 7962 results

  1. Weight management: lifestyle services for overweight or obese children and young people (PH47)

    This guideline has been updated and replaced by NICE guideline NG246.

  2. Weight management: lifestyle services for overweight or obese adults (PH53)

    This guideline has been updated and replaced by NICE guideline NG246.

  3. Obesity: working with local communities (PH42)

    This guideline has been updated and replaced by NICE guideline NG246.

  4. Preventing excess weight gain (NG7)

    This guideline has been updated and replaced by NICE guideline NG246.

  5. Obesity: identification, assessment and management (CG189)

    This guideline has been updated and replaced by NICE guideline NG246.

  6. Obesity prevention (CG43)

    This guideline has been updated and replaced by NICE guideline NG246.

  7. Liquid-based cytology for cervical screening (TA5)

    This guidance has been replaced by NICE technology appraisal guidance 69.

  8. Management of aggression, agitation and behavioural disturbances in dementia: valproate preparations (ESUOM41)

    This evidence summary has been updated and replaced by NICE guideline NG97.

  9. Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection (TA761)

    This guidance has been updated and replaced by NICE technology appraisal guidance 1043.

  10. Weight management before, during and after pregnancy (PH27)

    The recommendations in this guideline on weight management during pregnancy have been updated and replaced by NICE's guideline on maternal and child nutrition (NG247). The recommendations on weight management before and after pregnancy have been updated and replaced by NICE’s guideline on overweight and obesity management (NG246).

  11. Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer (TA760)

    This guidance has been updated and replaced by NICE technology appraisal guidance TA1042

  12. Rezum for treating benign prostatic hyperplasia (MIB158)

    This advice has been updated and replaced by NICE medical technologies guidance 49

  13. Trabecular stent bypass microsurgery for open angle glaucoma (IPG396)

    This guidance has been updated and replaced by NICE interventional procedure guidance 575.

  14. Off-pump coronary artery bypass (OPCAB) (IPG35)

    This guidance has been updated and replaced by NICE interventional procedure guidance 377.

  15. Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus: telavancin (ESNM44)

    This evidence summary has been withdrawn because the product is no longer available in the UK.